Context:

Internal FDA emails suggest officials downplayed pediatric deaths after COVID vaccination by altering autopsy conclusions, reducing the count from 10 to 7 and reframing cases to appear less likely linked to the vaccine. A recommended label change to warn of myocarditis with fatal outcomes for Moderna and Pfizer vaccines was not implemented, even as safety concerns persisted. The revelations come as CDC contracts worth about $1.24 billion with Pfizer for vaccines draw scrutiny, and as bipartisan pressure grows for transparency. The investigation is ongoing, with lawmakers and researchers expected to release more details in coming weeks.

Dive Deeper:

• The newly released emails show FDA staff identifying 10 deaths in children after COVID vaccination, then quickly reducing the tally to 7 and downgrading other cases, with what some described as guidance to minimize perceived risk.

• Two teenage boys who died days after the second Pfizer dose underwent autopsies by Yale pathologist James Gill; the emails indicate parvovirus testing influenced decisions, a factor Gill calls a red herring that shouldn’t exclude vaccine-related heart injury.

• Gill notes parvovirus can be widespread and detectable long after infection, and that the heart pathology linked to parvovirus differs from vaccine-associated myocarditis, making the downgrade arbitrary in his view.

• An FDA Division of Pharmacovigilance recommendation to update vaccine labels to warn about myocarditis with potentially fatal outcomes was not enacted, despite internal acknowledgment of safety concerns.

• A former FDA official described the emails as a coverup by FDA and CDC, accusing the agencies of downplaying vaccine risks in children even as safety questions persisted.

• Sen. Ron Johnson’s letters reference substantial CDC Pfizer vaccine contracts and portray a tension between safety oversight and acquisition activity, highlighting calls for greater transparency.

• The broader context is ongoing scrutiny of COVID-19 vaccine safety data for children, with the investigation expected to yield further details and reactions from involved parties in the weeks ahead.